Live News Categoriesequity

Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) News

Track canonical SquawkNews coverage tagged to 002210.KS, Dong Sung Bio Pharm.Co.,Ltd.. This hub brings together deduplicated headlines about kse, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 002210.KS Asset equity Sector Markets 90 days 1 Last 1,274 Updated Sep 30, 2026, 10:35 AM UTC Open live news feed

M Seoul High Court dismisses appeal over Dongsung Pharmaceutical rehabilitation plan Seoul High Court dismissed an immediate appeal against approval of Dongsung Pharmaceutical’s rehabilitation plan on Sept. 30, 2026, upheld the first-instance decision and ordered appeal costs. REGULATION | Sep 30, 2026, 10:35 AM UTC